SE9101433D0 - Recombinant dna sequence and its use - Google Patents

Recombinant dna sequence and its use

Info

Publication number
SE9101433D0
SE9101433D0 SE9101433A SE9101433A SE9101433D0 SE 9101433 D0 SE9101433 D0 SE 9101433D0 SE 9101433 A SE9101433 A SE 9101433A SE 9101433 A SE9101433 A SE 9101433A SE 9101433 D0 SE9101433 D0 SE 9101433D0
Authority
SE
Sweden
Prior art keywords
gram positive
recombinant dna
protein
cell wall
dna sequence
Prior art date
Application number
SE9101433A
Other languages
English (en)
Swedish (sv)
Inventor
Marianne Hansson
Mathias Uhlen
Per-Ake Nygren
Stefan Stahl
Original Assignee
Marianne Hansson
Mathias Uhlen
Nygren Per Ake
Stefan Stahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marianne Hansson, Mathias Uhlen, Nygren Per Ake, Stefan Stahl filed Critical Marianne Hansson
Priority to SE9101433A priority Critical patent/SE9101433D0/xx
Publication of SE9101433D0 publication Critical patent/SE9101433D0/xx
Priority to JP51056892A priority patent/JP3423712B2/ja
Priority to EP92910363A priority patent/EP0584167B1/en
Priority to DE69233375T priority patent/DE69233375T2/de
Priority to AT92910363T priority patent/ATE270335T1/de
Priority to AU17899/92A priority patent/AU664841B2/en
Priority to CA002103021A priority patent/CA2103021C/en
Priority to PCT/SE1992/000304 priority patent/WO1992020805A1/en
Priority to OA60434A priority patent/OA09866A/en
Priority to US08/629,039 priority patent/US5958736A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/883—Staphylococcus aureus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
SE9101433A 1991-05-13 1991-05-13 Recombinant dna sequence and its use SE9101433D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9101433A SE9101433D0 (sv) 1991-05-13 1991-05-13 Recombinant dna sequence and its use
JP51056892A JP3423712B2 (ja) 1991-05-13 1992-05-11 シグナルペプチド、選択的相互作用ポリペプチド及び膜固定配列をコードする組換えｄｎａ配列
EP92910363A EP0584167B1 (en) 1991-05-13 1992-05-11 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
DE69233375T DE69233375T2 (de) 1991-05-13 1992-05-11 Für ein signalpeptid, ein selektiv wechselwirkendes polypeptid und eine membranankersequenz kodierende rekombinante dns
AT92910363T ATE270335T1 (de) 1991-05-13 1992-05-11 Für ein signalpeptid, ein selektiv wechselwirkendes polypeptid und eine membranankersequenz kodierende rekombinante dns
AU17899/92A AU664841B2 (en) 1991-05-13 1992-05-11 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
CA002103021A CA2103021C (en) 1991-05-13 1992-05-11 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
PCT/SE1992/000304 WO1992020805A1 (en) 1991-05-13 1992-05-11 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
OA60434A OA09866A (en) 1991-05-13 1993-11-11 Recombinant DNA coding for signal peptide; selective interacting polypeptide and membrane anchoring sequence.
US08/629,039 US5958736A (en) 1991-05-13 1996-04-08 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101433A SE9101433D0 (sv) 1991-05-13 1991-05-13 Recombinant dna sequence and its use

Publications (1)

Publication Number Publication Date
SE9101433D0 true SE9101433D0 (sv) 1991-05-13

Family

ID=20382707

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101433A SE9101433D0 (sv) 1991-05-13 1991-05-13 Recombinant dna sequence and its use

Country Status (10)

Country Link
US (1) US5958736A (xx)
EP (1) EP0584167B1 (xx)
JP (1) JP3423712B2 (xx)
AT (1) ATE270335T1 (xx)
AU (1) AU664841B2 (xx)
CA (1) CA2103021C (xx)
DE (1) DE69233375T2 (xx)
OA (1) OA09866A (xx)
SE (1) SE9101433D0 (xx)
WO (1) WO1992020805A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
WO1993018163A2 (en) * 1992-03-13 1993-09-16 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US6114147A (en) * 1993-02-10 2000-09-05 Unilever Patent Holdings Immobilized proteins with specific binding capacities and their use in processes and products
US6740734B1 (en) * 1994-01-14 2004-05-25 Biovitrum Ab Bacterial receptor structures
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
FR2726577B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
FR2726471B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
WO1996017951A2 (en) 1994-12-09 1996-06-13 Rpms Technology Limited Identification of genes responsible for in vivo survival of microorganisms
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
FR2766091A1 (fr) * 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee
DK1108034T3 (da) 1998-09-04 2008-11-10 Emergent Product Dev Uk Ltd Svækkede salmonella SPI2-mutanter som antigenbærere
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
EP1377306A1 (en) * 2001-03-09 2004-01-07 Dyax Corp. Serum albumin binding moieties
EP2075256A2 (en) 2002-01-14 2009-07-01 William Herman Multispecific binding molecules
US20040009534A1 (en) * 2002-06-14 2004-01-15 Dyax Corporation Protein analysis
WO2004001064A2 (en) * 2002-06-21 2003-12-31 Dyax Corporation Serum protein-associated target-specific ligands and identification method therefor
WO2008127457A2 (en) * 2006-12-06 2008-10-23 Repligen Corporation Nucleic acids encoding recombinant protein a
WO2008129428A2 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
EP2326344A4 (en) 2008-06-16 2013-08-07 Prokarium Ltd VACCINES WITH SALMONELLA VECTOR AGAINST CHLAMYDIA AND METHOD OF ADMINISTRATION
CN107847601A (zh) 2015-06-04 2018-03-27 南加利福尼亚大学 Lym‑1和lym‑2靶向的car细胞免疫疗法
CA3065946A1 (en) 2017-06-05 2018-12-13 Research Institute At Nationwide Children's Hospital Enhanced modified viral capsid proteins
CA3145385A1 (en) 2019-07-08 2021-01-14 Steven D. Goodman Antibody compositions for disrupting biofilms
AU2022358523A1 (en) 2021-09-30 2024-03-14 The Board Of Regents Of The Universityof Texas System Slc13a5 gene therapy vectors and uses thereof
WO2023096996A2 (en) 2021-11-24 2023-06-01 Research Institute At Nationwide Children's Hospital Chimeric hsv expressing hil21 to boost anti-tumor immune activity
WO2023102406A1 (en) 2021-12-01 2023-06-08 The Board Of Regents Of The Univesity Of Texas System Vector genome design to express optimized cln7 transgene
WO2023102518A1 (en) 2021-12-03 2023-06-08 The Board Of Regents Of The University Of Texas System Gnao1 gene therapy vectors and uses thereof
WO2023147476A1 (en) 2022-01-28 2023-08-03 The Board Of Regents Of The University Of Texas System Transgene casette designed to express the human codon-optimized gene fmr1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573193B2 (en) * 1982-11-23 1988-06-02 Bio-Response Inc. Method for isolating cells
US5200327A (en) * 1985-11-06 1993-04-06 Cangene Corporation Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
DE3852304T3 (de) * 1987-03-02 1999-07-01 Enzon Lab Inc Organismus als Träger für "Single Chain Antibody Domain (SCAD)".
DE3744595A1 (de) * 1987-12-31 1989-07-13 Andreas Dr Plueckthun Verfahren zur gentechnischen herstellung von antikoerpern
WO1989007140A1 (en) * 1988-02-05 1989-08-10 Commonwealth Scientific And Industrial Research Or Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence

Also Published As

Publication number Publication date
WO1992020805A1 (en) 1992-11-26
DE69233375D1 (de) 2004-08-05
DE69233375T2 (de) 2005-07-14
ATE270335T1 (de) 2004-07-15
US5958736A (en) 1999-09-28
AU664841B2 (en) 1995-12-07
CA2103021C (en) 2000-07-04
EP0584167B1 (en) 2004-06-30
EP0584167A1 (en) 1994-03-02
OA09866A (en) 1994-08-15
AU1789992A (en) 1992-12-30
CA2103021A1 (en) 1992-12-01
JPH07502640A (ja) 1995-03-23
JP3423712B2 (ja) 2003-07-07

Similar Documents

Publication Publication Date Title
SE9101433D0 (sv) Recombinant dna sequence and its use
EP1092774A3 (en) Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof
HK1013847A1 (en) Gdf-1 and uog-1 proteins
DE69333802T8 (de) Äusseres membranprotein von haemophilus
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
AU3664695A (en) Infective protein delivery system
HUP0001650A2 (hu) Javított expressziós vektorok
AU2013688A (en) Dna constructs containing a kluyveromyces alpha-factor leader sequence for directing secretion of heterologous polypeptides
NO864759D0 (no) Eutaryotiske fusjonsproteiner, fremstilling og anvendelse derav samt middel til gjennomfoering av fremgangsmaaten.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
AU3192889A (en) T cell activation markers
DK0531300T3 (da) Variant-CD44-overfladeproteiner, DNA-sekvenser, som koder herfor, antistoffer mod disse proteiner samt deres anvendelse til diagnostik og terapi
EP0383837A4 (en) Alveolar surfactant proteins
DK0614980T3 (da) Trans-dominante TAT-varianter fra humant immundeficiens-virus
EP1380648A3 (en) Recombinant DNAase B derived from streptococcus pyogenes
CA2083177A1 (en) Alveolar surfactant proteins
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
AU7873798A (en) N-terminally extended proteins expressed in yeast
AU5776799A (en) Modified hcv peptide vaccines
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
ES2012283A6 (es) Procedimiento de obtencion de una proteina de endotoxina de efecto insecticida.
EP0345792A3 (en) Htlv-i / hiv-1 fusion proteins
WO1999055862A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
Tekamp-Olson Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences
EP0953642A4 (en) ANTIGENIC PROTEIN DRAWN FROM THE INFECTIOUS LARYNGO-TRACHEITIS VIRUS